{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Valeant Pharmaceuticals interim chief executive Howard B Schiller says it is unclear when J Michael Pearson will return as chief; Pearson is recovering from pneumonia.", "type_of_material": "News", "word_count": "475", "lead_paragraph": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "pub_date": "2016-01-14T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Ailing Valeant Chief&#8217;s Return Date Is Uncertain ", "print_headline": "Valeant Official Says Chief&#8217;s Return Date Is Uncertain "}, "snippet": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "multimedia": [{"height": 126, "url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 431, "url": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "431", "xlarge": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/01/14/business/ailing-valeant-chiefs-return-date-is-uncertain.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pearson, John Michael (1959- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Appointments and Executive Changes", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Schiller, Howard B", "name": "persons"}], "blog": [], "_id": "5696f7a038f0d865e6c34986", "source": "The New York Times"}